GTG 17.2% 7.7¢ genetic technologies limited

future, page-2

  1. 1,181 Posts.
    lightbulb Created with Sketch. 12
    I do think BrevaGEN will be enough and that is why they are putting all their eggs into this basket (selling down their holding in ImmunAID and not focusing so much on .

    However if you compare Pacific Edge, they have gone into the US after us and have a much higher MC.

    Why is that?

    IMO, I think it is MJ. Nothing against him but if I compare AHZ, AVX had a large holding in AHZ. When they sold out completely, look at where AHZ SP is now. I think large holders can hold the SP back especially if they can be destabilising (MJ pretty much rolled the previous board). But I don't know whether he will sell out unless the SP is much higher than where it is now.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
7.7¢
Change
-0.016(17.2%)
Mkt cap ! $10.18M
Open High Low Value Volume
8.5¢ 8.5¢ 7.6¢ $30.27K 378.4K

Buyers (Bids)

No. Vol. Price($)
2 10422 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5500 1
View Market Depth
Last trade - 15.58pm 26/06/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.